Why partnerships are needed
Most health-related issues have a global nature and require a global solution. The EU alone will not crack the challenge of implementing better healthcare for all.
The ability to attract international stakeholders and their resources into EU–led collaborations will help the EU to combine best skills and outcomes, and deliver tangible results to patients.
International cooperation is therefore not an option but a fundamental and inherent component of health research and innovation.
Initiatives with European Commission membership or contribution
Global Research Collaboration for Infectious Disease Preparedness (GloPID-R)
Since infectious diseases do not respect borders and spread rapidly, GloPID-R aims to improve the collaboration of funders that is paramount to establishing a rapid and effective global research response. The goal is to establish a response within 48 hours of an outbreak.
Global Alliance for Chronic Diseases (GACD)
Develops and facilitates innovative research collaborations between low-middle-income and high-income countries in the fight against chronic diseases.
Human Frontier Science Programme organisation (HFSP)
A global intercontinental programme, which finances innovative and interdisciplinary basic research at the frontier of the life sciences.
International Cancer Genome Consortium (ICGC)
Accelerates research into the causes and the control of cancer by generating comprehensive catalogues of genomic abnormalities in cancer tumours.
International Initiative for Traumatic Brain Injury Research (InTBIR)
Addresses, since 2011, the overall problem of traumatic brain injury (TBI) by establishing best practices in treatment, through strengthened global cooperation and collaboration.
International Human Epigenome Consortium (IHEC)
Aims to understand the role of the human epigenome as cause of diseases and in the maintenance of health by providing 1000 high-resolution reference epigenome maps to the research community.
International Human Microbiome Consortium (IHMC)
Aims to understand the role of the human microbiome as cause of diseases and in the maintenance of health and how to use that knowledge to improve the ability to prevent and treat disease.
Stimulates, better coordinates & maximises output of rare disease research efforts around the world. IRDiRC’s vision is to enable all people living with a rare disease to receive an accurate diagnosis, care, and available therapy within one year of coming to medical attention.
European and Developing Countries Clinical Trails Partnership 2 (EDCTP2)
Partnership of 14 European countries, 16 African countries and the European Union to support the clinical development of effective, safe, accessible, suitable and affordable medical interventions for poverty-related and neglected diseases in sub-Saharan Africa. Contributes to the reduction of the social and economic burden caused by these diseases in developing countries.